Article

Ophthalmic solution reformulated as nasal spray for allergies

Fort Worth, TX-A nasal formulation of olopatadine HCl ophthalmic solution 0.1% (Patanol, Alcon) reduced seasonal allergic rhinitis symptoms compared with placebo, according to phase III study results.

Related Videos
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Elkin: Talking about the importance of pediatric eye health and safety
Related Content
ARVO announces Swathi Kaliki, MD, as recipient of 2025 Ludwig von Sallmann Clinician-Scientist Award
March 15th 2025

ARVO announces Swathi Kaliki, MD, as recipient of 2025 Ludwig von Sallmann Clinician-Scientist Award

ROP: Treating and preventing blindness in preterm babies
October 18th 2021

ROP: Treating and preventing blindness in preterm babies

The search for an antifibrotic drug for use with pediatric glaucoma devices
March 5th 2025

The search for an antifibrotic drug for use with pediatric glaucoma devices

Managing a changing landscape of IRD pediatric cases
May 10th 2021

Managing a changing landscape of IRD pediatric cases

Hyperacute outer retinal dysfunction may be an underrecognized pediatric disorder
February 22nd 2025

Hyperacute outer retinal dysfunction may be an underrecognized pediatric disorder

Study highlights strong parental cooperation in preschool vision screening
February 14th 2025

Study highlights strong parental cooperation in preschool vision screening

© 2025 MJH Life Sciences

All rights reserved.